CCLCS program final.indd

CONFERENCE
COLLABORATIVE
CACMLE (Colorado Association for Continuing Medical Laboratory Education, Inc.)
6825 E. Tennessee Ave. Ste 111
Denver, Colorado 80224-1629
Phone: 303-321-1734 • Fax: 303-321-9231
email: [email protected] • Website: www.CACMLE.org
Clinical Laboratory
through
COLLABORATION
Permit No. 1203
Denver CO
US POSTAGE PAID
Non-Profit Org
A Clinical Laboratory Continuing Education event
organized by
ASCLS-Colorado
ASCLS-Wyoming
CACMLE
CLMA-Centennial Chapter
May 13 – May 15, 2009
Schedule at a Glance
Wednesday, May 13
7:30-8:30 Registration
8:00-9:00 Continental Breakfast
8:30-8:45 Opening ceremony
and ASCLS-CO awards
8:45-9:45 Keynote
9:45–10:00 Break
10:00-11:30 Breakout Sessions
11:30-1:30 Lunch with Vendors
1:30-3:00 Breakout Sessions
3:00-3:15 Break
3:15-4:45 Breakout Sessions
4:45-5:00 P.A.C.E.
Thursday, May 14
7:30-8:30 Registration
8:00-9:00 Continental Breakfast
8:30-8:45 Opening ceremony
and ASCLS-WY awards
8:45-9:45 General Session
9:45-10:00 Break
10:00-11:30 Breakout Sessions
11:30-1:30 Lunch with Vendors
1:30-3:00 Breakout Sessions
3:00-3:15 Break
3:15-4:45 Breakout Sessions
4:45-5:00 P.A.C.E.
Friday, May 15
7:30-8:30 Registration
8:00-9:00 Continental Breakfast
8:30-8:45 Opening Ceremony
8:45-9:45 General Session
9:45-10:00 Break
10:00-11:30 Breakout Sessions
11:30-1:30 Lunch with Vendors
1:30-3:00 Breakout Sessions
3:00-3:15 Break
3:15-4:45 Breakout Sessions
4:45-5:00 P.A.C.E.
* Please bring this program to the conferrence
** Program schedule is tentative and
subject to change
Friday, May 15, 2009 • 1:30 - 3:00pm
Come visit
us online!
• Prior to attending the
session, attendees will
need to print handouts by
visiting us online at:
www.clcconline.org
A username and password
is required for printing
conference materials and
will be provided with your
registration confirmation.
(Handouts will NOT be
provided at the session.)
• Directions and a map are
available online.
• Registration is available at
www.clcconline.org and
www.coclma.org and credit
cards will be accepted.
Session #25 Eeek! Newborn Differentials
— Janet Oertli, MT(ASCP), CLS(NCA), Primary Children’s Medical Center
This session presents pictures, pictures and more pictures from newborn peripheral blood smears,
along with tips and tricks for identification of newborn blood cells. Case studies help tie it all together.
Session #26 Fungal Cultures and Susceptibility Testing
— Nancy Madinger, MD, University Hospital, Denver
This session will address the changing epidemiology of fungal infections and review advances in rapid
diagnostics and new products applicable to clinical microbiology. We will review antifungal drugs and
evolving recommendations for antifungal susceptibility testing.
Session #27 Blood Bank Case Studies
— Monica LaSarre, MT(ASCP)SBB, Bonfils Blood Center
The identification of a passively acquired red cell antibody can cause unique challenges for the blood
bank. Consideration must be given to the source of the antibody, the appropriate reporting of the
antibody (auto- vs. allo-), and the transfusion recommendations for an individual with such an antibody. A review of the history of Rh disease as well as Prenatal and ITP patient cases will be discussed.
Friday, May 15, 2009 • 3:15 - 4:45pm
Session #28 HbA1c Standardization to Screening?
— Scott Joksch, Bio-Rad
HbA1c method standardization has been achieved within United States. Screening for diabetics and
pre-diabetics: Why use HbA1c in the screening process? What changes are needed to use HbA1c in
the screening process and how will they impact your laboratory?
Session #29 Molecular Diagnostics and Identification of Specific Pathogens
— Hugh Maguire, PhD, Colorado Dept of Public Health and Environment
Several methods will be described that are used during surveillance and outbreak investigation in
the setting of a public health laboratory. How molecular techniques are employed during a rapid
response or to create a genetic profile will be presented. The advantages and limitations will be addressed using specific examples of recent outbreaks.
• CACMLE Annual Meeting,
Wed, May 13, 5:00-7:00,
with a special guest
performance by Dr. Kevin
Fitzgerald. Refreshments
served. Room to be
announced.
• ASCLS-CO meeting,
followed by IMSS planning
committee meeting,
Thursday, May 14, 5:00 - ?,
room to be announced
•ASCLS-WY meeting,
Thursday, May 14, 5:00 - ?,
room to be announced
Session #30 The Evaluation and Management of Platelet Refractoriness
— Kelley Capocelli, MD, University of Colorado Denver School of
Medicine/The Children’s Hospital
This talk represents an overview of the topic of platelet refractoriness, including discussion of assessing patient response to the platelet transfusion, the steps to take when concerns of platelet refractoriness arise and management of platelet transfusions in the setting of platelet refractoriness.
Please visit with your vendors in the exhibits area each
day. We are grateful for their continued support and
want them to have the greatest opportunity to speak
with their customers during this event.
Session #16 Emerging Blood Transfusion Practices and Revitalization of the Hospital
Transfusion Committee
— Kathleen Houston, MT(ASCP)SBB, CQA(ASQ), The Children’s Hospital
This session will discuss current initiatives to reduce unnecessary blood transfusions and to better
manage precious blood resources. In addition, it will describe the AABB’s newly-launched Biovigilance Network for national tracking and trending of adverse transfusion-related events.
Session #17 Diagnosis and Classification of AML Using the New WHO Classification
—Sherrie Perkins, MD, PhD, ARUP
This session will address the appropriate workup and diagnosis of AML using the new WHO guidelines. The session will examine the importance of morphology, immunophenotype, cytogenetics
and molecular testing in making a diagnosis of AML. The session will also address the new impact of
molecular testing on prognosis and treatment of AML.
Thursday, May 14, 2009
•
3:15 - 4:45pm
Session #18 Pulsed Field Gel Electrophoresis, PulseNet, and Foodborne
Illness Epidemiology
— Wanda Manley, MS, WY Public Health Laboratory
A PowerPoint presentation that explains the use of PFGE and PulseNet in your public health labs to
detect and track foodborne illness. We will talk about the PFGE process, introduce PulseNet, and
talk about foodborne illness epidemiology during an outbreak.
Session #19 Serum Free Light Chain Assay for Diagnosis and Monitoring of Multiple
Myeloma and Other Monoclonal Gammopathies
— Anne Sherwood, PhD, Binding Site
The serum free light chain assay, FreeliteTM, is a highly specific, quantitative and fully automated approach to measure free lambda and kappa light chains in the serum. FreeliteTM provides a sensitive
indicator of patient status in the diagnosis, treatment and remission of Multiple Myeloma and other
B-cell dyscrasias. Concepts of the biology of free light chain processing in vivo as it affects test results
in clinical samples will be presented and utilization of the free light chain assay and κ/λ free light
chain ratios for risk stratification, diagnosis and monitoring of monoclonal gammopathies for patient
management will be discussed using case studies.
General Sessions
Wednesday, May 13, 2009
Keynote Address
•
8:45 - 9:45am
Government Affairs Update
— Linda Comeaux, CLS(NCA), Arapahoe Community College and Joe Miles, MHS,
MT(ASCP), Frontline Laboratory Network
Government Affairs activities by ASCLS and CLMA will be shared. Information about how the new
Administration will impact the Clinical Laboratory legislative processes and any current legislative
issues will also be discussed.
Thursday, May 14, 2009
General Session
•
8:45 - 9:45am
Friday, May 15, 2009
•
10:00 - 11:30am
Session #22 Vitamin D: Clinical Symptoms of Deficiency or Over Abundance
— Ravinder Singh, PhD, Mayo Labs
Dr Singh will present various methodologies for Vitamin D testing, recommendations of acceptable
levels, and clinical cases of Vitamin D deficiency and overabundance.
Session #23 Emerging Transfusion-Transmitted Diseases
— Susan Epperson, MT(ASCP)SBB, Poudre Valley Hospital
No session description available at time of printing
Session #24 The Leadership Dilemma
— JR Constance, MHA, MT(ASCP), CLCC
There are many leadership styles, but not all of them are effective. What makes a good leader, and
more importantly what is it about a leader that makes someone want to follow them? Attendees to
this session will learn about various leadership styles, with a focus on the qualities of a good leader
and what makes people want to follow them, and the tools that almost anyone can use to become
that good leader.
Session #11
Lessons Learned from Starbucks: Making ASCLS Extraordinary
— Scott Aikey, MS, CLDir/CLS(NCA), President ASCLS
The Starbucks Corporation has revolutionized the personalized customer experience model. Their
five principles for turning ordinary into extraordinary to grow their business and customer base has direct application to ASCLS. This session will explore how ASCLS can take advantage of those lessons
learned and apply them to our situation to grow our organization.
Friday, May 15, 2009
•
8:45 - 9:45am
Session #21
The Importance of Disease to Human Health
— Gerald Callahan, PhD, Colorado State University
Though routinely maligned, our diseases shape each of us from our births to our deaths. Seeing
disease as a normal and essential part of human development can change the ways we think about
health and health care.
Session #20 Laboratory Compliance 101, Setting up a Laboratory Compliance Program
— Theresa Mayer, MT(ASCP), CLS(NCA), Exempla Healthcare
This session will discuss how a laboratory compliance program was set up for Exempla Healthcare.
A short lecture on how the system was set up will be given followed by a Q&A session with questions submitted prior to the session. Please submit questions for the speaker by May 10, 2009,
to:[email protected].
Session #1
Hotel Information
Red Lion Hotel Denver Southeast
3200 S. Parker Road
Aurora, CO 80014
For Room Reservations call:
303-695-1700 or 800-962-7672
State you are part of the CLCC Discounted
Conference Room Rate: $84/night
Call by 4/21/09 to guarantee the discounted rate
Directions to hotel available at www.clcconline.org
Breakouts
Wednesday, May 13, 2009 • 3:15 - 4:45pm
Session #8 Disaster Contingency Planning
— Tom Wachter, MBA/HCM, SLS(ASCP), ARUP
Wednesday, May 13, 2009 • 10:00 - 11:30am
Session #2 Interferon Gamma Release Assays (IGRAs) and Screening for MTB
— Diane Weed, MA, MT(ASCP), Denver Health Medical Center
This session will review the available tests for tuberculosis screening, including the new interferon
gamma release assays (IGRAs).
Session #3 Electrolyte Case Studies
— Joan Polancic, MSEd, CLS(NCA), ASCLS
Electrolyte test results are often difficult to explain due to their complicated regulation mechanisms
(renal and hormonal). In this session, case studies will be used to guide the participants in understanding the usefulness of commonly used electrolyte tests, including sodium, potassium, chloride,
bicarbonate, and magnesium. Causes, symptoms, and classification of disorders will be discussed.
Beneficial resources that describe how the tests can be used for monitoring and treatment will be
shared.
Session #4 Clinical Significance, Detection and Identification of the D Antigen
— Anna Loveless, MT(ASCP)SBB , Cheyenne Regional Medical Center
This discussion will cover the history, clinical significance, and laboratory assays available to detect
and identify D antigen and antibody.
Wednesday, May 13, 2009 • 1:30 - 3:00pm
Session #5 Applying the Quality System Essentials to a Quality System Model. How to
Prepare a Quality Management Plan for your System
— Nadine Alexander, MS, MT(ASCP), Memorial Hospital North, Colorado Springs
This presentation will cover safety and quality issues from the entire hospital organization down to the
lab. Patient safety and quality can be best addressed through a comprehensive, system wide quality
management plan. Utilizing the CLSI’s 12 Quality System Essentials (QSE) as a framework and many of
the policies and procedures already in place in our organizations, we are well on our way to forming a
Quality Management Plan (QMP) that spans the entire path of workflow.
Session #6 What’s the Scoop on Poop? An Update on Gastrointestinal Infections
— Jay Lieberman, MD, Focus Diagnostics
Gastrointestinal infections, caused by bacteria, viruses, and parasites, result in significant morbidity
and mortality in the United States and globally. Clostridium difficile is a significant cause of hospitalacquired diarrhea, and the spread of a more virulent strain has led to cases, including severe disease,
in populations classically not thought to be at risk. Unfortunately, the assays used commonly to detect
C. difficile toxin are not sufficiently sensitive, and new antigen detection and molecular assays may
play an increasingly important role in diagnostic testing. E. coli O157:H7 and other Shiga toxinproducing E. coli can lead to hemorrhagic colitis and hemolytic uremic syndrome. New recommendations will result in an increased likelihood of detecting these pathogens in patients with diarrhea.
Among the most common viral causes of gastroenteritis are noroviruses and rotavirus. The use of a
live, oral rotavirus vaccine in infants has led to marked declines in rotavirus disease in the U.S.
Session #7 Why are Clinicians Requesting More and More Point of Care Testing in your
Emergency Department?
— Wendy Neil, RRT-NRP, Abbott Point of Care
This session will address critical issues that Emergency Departments are facing. Additionally, how to
improve Pre Analytical processes by bringing the lab to the patient. Lastly, we will review the impacts
of rapid diagnosis and disposition of NSTEMI, heart failure, sepsis patients.
This session will provide an overview of the disaster and contingency planning process for laboratory
operations. Disaster and contingency planning are designed to ensure continued patient care in the
event of a crisis affecting, or posing an imminent threat to, facility operations. This presentation will
draw from the experience of a large single-site clinical testing laboratory, and will include practical
“take home” ideas to prepare your own facility, administration and staff.
Session #9 Monitoring Antithrombotic Therapy
— George Fritsma, MS, MT(ASCP)
Physicians have used the same anticoagulants, coumadin, and heparin, for at least 50 years. These
drugs have saved countless lives. However they are dangerous, have a narrow therapeutic window,
and require continuous laboratory monitoring. Since 1990, we have added safer forms of heparin,
direct thrombin inhibitors, and anti-platelet drugs aspirin and clopidogrel. Now we await several new
oral antithrombotics just emerging from clinical trials.
Session #10 Lab Considerations for the Reproductive Endocrinologist
— Kevin Bachus, MD, Rocky Mountain Center for Reproductive Medicine
Through a format of didactic lecture, clinical case examples, and informal question and answer session, the speaker will discuss the most common clinical scenarios where the reproductive endocrinologist will require laboratory services in order to provide better patient care.
Thursday, May 14, 2009 • 10:00 - 11:30am
Session #12 The Electronic Health Record: Past, Present, Future, and the Impact on
the Clinical Laboratory
— Scott Aikey, MS, CLDir/CLS(NCA), CLCC
This session will describe the drivers for change, which is leading to the implementation of electronic
health record systems across the country. In addition, the attendee will be afforded the opportunity
to view what a clinical electronic health record system looks like in use and how the laboratory component is integrated into the workflow. Ways in which laboratory professionals can get involved in the
implementation and maintenance will also be discussed.
Session #13 Celiac Disease: It’s More Than Just a Bad Stomach Ache
— Ginger Weeden, CLS(NCA), MT(ASCP), Biorad
Celiac disease has garnered more attention over the past several years since the offending antibodies have been identified and its relationship with other autoimmune disease and non-autoimmune
diseases have been uncovered. Learn about the clinical laboratory tests used for diagnosis, the other
tools that your physicians are using and what the consequences are of misdiagnosis or delayed
diagnosis.
Session #14 Myeloproliferative Neoplasms and the New WHO Classifications
— Sherry Perkins, MD, PhD, ARUP
Chronic myeloproliferative diseases are clonal hematologic neoplasms that are often difficult to
accurately diagnose in the laboratory. This session will review changes in diagnosis and diagnostic
approach to chronic myeloproliferative neoplasms according to the new WHO classification of hematologic neoplasms. The lecture will focus on clinical, morphologic and molecular features that are
important in establishing a diagnosis.
Thursday, May 14, 2009 • 1:30 - 3:00pm
Session #15 Diagnosing Vaginal Infections with the Wet Prep Procedure
—Teri Anderson, MT(ASCP), Denver Health
This presentation will review the etiology as well as compare and contrast the clinical manifestations
of trichomoniasis, candidiasis and bacterial vaginosis. Relevant laboratory and diagnostic procedures
will be discussed.